.@pcvblack – Tumour heterogeneity is the Achilles heel of targeted Rx. Few mutations shared by all tumour sites. Many just in primary or in Mets. ctDNA might help to overcome this limitation. #eau18
.@pcvblack – Tumour heterogeneity is the Achilles heel of targeted Rx. Few mutations shared by all tumour sites. Many just in primary or in Mets. ctDNA might help to overcome this limitation. #eau18